Literature DB >> 19136453

Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects.

Måns Jergil1, Kim Kultima, Anne-Lee Gustafson, Lennart Dencker, Michael Stigson.   

Abstract

The utility of an in vitro system to search for molecular targets and markers of developmental toxicity was explored, using microarrays to detect genes susceptible to deregulation by the teratogen valproic acid (VPA) in the pluripotent mouse embryonal carcinoma cell line P19. Total RNA extracted from P19 cells cultured in the absence or presence of 1, 2.5, or 10mM VPA for 1.5, 6, or 24 h was subjected to replicated microarray analysis, using CodeLink UniSet I Mouse 20K Expression Bioarrays. A moderated F-test revealed a significant VPA response for 2972 (p < 10(-3)) array probes (19.4% of the filtered gene list), 421 of which were significant across all time points. In a core subset of VPA target genes whose expression was downregulated (68 genes) or upregulated (125 genes) with high probability (p < 10(-7)) after both 1.5 and 6 h of VPA exposure, there was a significant enrichment of the biological process Gene Ontology term transcriptional regulation among downregulated genes, and apoptosis among upregulated, and two of the downregulated genes (Folr1 and Gtf2i) have a knockout phenotype comprising exencephaly, the major malformation induced by VPA in mice. The VPA-induced gene expression response in P19 cells indicated that approximately 30% of the approximately 200 genes known from genetic mouse models to be associated with neural tube defects may be potential VPA targets, suggestive of a combined deregulation of multiple genes as a possible mechanism of VPA teratogenicity. Gene expression responses related to other known effects of VPA (histone deacetylase inhibition, G(1)-phase cell cycle arrest, induction of apoptosis) were also identified. This study indicates that toxicogenomic responses to a teratogenic compound in vitro may correlate with known in vitro and in vivo effects, and that short-time (< or =6 h) exposures in such an in vitro system could provide a useful component in mechanistic studies and screening tests in developmental toxicology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136453     DOI: 10.1093/toxsci/kfp002

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  15 in total

1.  Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variability.

Authors:  Eva Also-Rallo; Laura Alías; Rebeca Martínez-Hernández; Lidia Caselles; María J Barceló; Montserrat Baiget; Sara Bernal; Eduardo F Tizzano
Journal:  Eur J Hum Genet       Date:  2011-05-25       Impact factor: 4.246

2.  Reduction in valproic acid-induced neural tube defects by maternal immune stimulation: role of apoptosis.

Authors:  Mural Mallela; Theresa Hrubec
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2012-07-05

3.  Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.

Authors:  Anne K Krug; Raivo Kolde; John A Gaspar; Eugen Rempel; Nina V Balmer; Kesavan Meganathan; Kinga Vojnits; Mathurin Baquié; Tanja Waldmann; Roberto Ensenat-Waser; Smita Jagtap; Richard M Evans; Stephanie Julien; Hedi Peterson; Dimitra Zagoura; Suzanne Kadereit; Daniel Gerhard; Isaia Sotiriadou; Michael Heke; Karthick Natarajan; Margit Henry; Johannes Winkler; Rosemarie Marchan; Luc Stoppini; Sieto Bosgra; Joost Westerhout; Miriam Verwei; Jaak Vilo; Andreas Kortenkamp; Jürgen Hescheler; Ludwig Hothorn; Susanne Bremer; Christoph van Thriel; Karl-Heinz Krause; Jan G Hengstler; Jörg Rahnenführer; Marcel Leist; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2012-11-21       Impact factor: 5.153

4.  Epilepsy drugs and effects on fetal development: Potential mechanisms.

Authors:  Leila Etemad; Mohammad Moshiri; Seyed Adel Moallem
Journal:  J Res Med Sci       Date:  2012-09       Impact factor: 1.852

5.  Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling.

Authors:  A Gupta; T G Schulze; V Nagarajan; N Akula; W Corona; X-y Jiang; N Hunter; F J McMahon; S D Detera-Wadleigh
Journal:  Pharmacogenomics J       Date:  2011-03-08       Impact factor: 3.550

6.  A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors.

Authors:  Eugen Rempel; Lisa Hoelting; Tanja Waldmann; Nina V Balmer; Stefan Schildknecht; Marianna Grinberg; John Antony Das Gaspar; Vaibhav Shinde; Regina Stöber; Rosemarie Marchan; Christoph van Thriel; Julia Liebing; Johannes Meisig; Nils Blüthgen; Agapios Sachinidis; Jörg Rahnenführer; Jan G Hengstler; Marcel Leist
Journal:  Arch Toxicol       Date:  2015-08-14       Impact factor: 5.153

7.  Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells.

Authors:  Tanja Waldmann; Eugen Rempel; Nina V Balmer; André König; Raivo Kolde; John Antonydas Gaspar; Margit Henry; Jürgen Hescheler; Agapios Sachinidis; Jörg Rahnenführer; Jan G Hengstler; Marcel Leist
Journal:  Chem Res Toxicol       Date:  2014-01-21       Impact factor: 3.739

8.  Teratogen screening: state of the art.

Authors:  Julia Schumann
Journal:  Avicenna J Med Biotechnol       Date:  2010-07

9.  Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells.

Authors:  K Meganathan; S Jagtap; S P Srinivasan; V Wagh; J Hescheler; J Hengstler; M Leist; A Sachinidis
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

10.  From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects.

Authors:  Nina V Balmer; Stefanie Klima; Eugen Rempel; Violeta N Ivanova; Raivo Kolde; Matthias K Weng; Kesavan Meganathan; Margit Henry; Agapios Sachinidis; Michael R Berthold; Jan G Hengstler; Jörg Rahnenführer; Tanja Waldmann; Marcel Leist
Journal:  Arch Toxicol       Date:  2014-06-17       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.